. Author manuscript; available in PMC: 2020 Sep 1.

Published in final edited form as: Psychopharmacology (Berl). 2019 Mar 27;236(9):2635–2640. doi: 10.1007/s00213-019-05235-x

Table 4.

Peak Change from Baseline in Psychotomimetic and Perceptual-altering Effects

	Mean (SD)		t (paired t-test)	df	p-value
	Haloperidol	Placebo	t (paired t-test)	df	p-value
PANSS positive	1.1 (0.35)	2.9 (0.92)	2.77	8	0.024
PANSS negative	2.13 (1.46)	1.5 (1.02)	−0.73	8	0.487
PANSS general psychopathology	2.44 (1.81)	3.4 (3.24)	1.189	8	0.269
PANSS total	5.55 (1.75)	7.8 (2.46)	1.67	8	0.133
CADSS-Clinician Rated	3.33 (1.05)	4.6 (1.45)	1.04	8	0.255
CADSS-Subjective	3.22 (1.01)	6.2 (1.96)	1.24	8	0.331

PANSS: Positive and Negative Syndrome Scale. CADSS: Clinician-Administered Dissociative States Scale.